EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The Impact of Adversity and Family Conflict on Risk for Future Substance Use Among Young Adolescents in the Adolescent Brain Cognitive Development Study (ABCD Study): A Cohort Analysis

Sarah M. Rodrigues, Afsaneh Saghafi, Qiao Wang, Sanghyuk S. Shin, Sarahjane L. Dube, Annabel Diestel, Robin Stevens, Dawn T. Bounds

Journal of Child and Adolescent Psychiatric Nursing · 2025-05 · 38 (2)

DOI: 10.1111/jcap.70017 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Problem Early initiation of substance use ( 14 years old) constitutes a key target for intervention strategies. This study investigated associations between exposure to adverse childhood experiences (ACEs) and risk for future substance use among young adolescents in the United States (US); the moderating effect of family conflict was also explored. Methods Mixed‐effects modeling was used to analyze self‐report data collected from adolescents and parents at baseline and 3‐year follow‐up (Y3) in the Adolescent Brain Cognitive Development Study (ABCD Study) (Data Release 5.1, 2016–2022, US). Findings After adjusting for socio‐demographic covariates, significant positive associations were found between adolescent ACEs score at baseline (ages 9–10) and risk for future alcohol ( b = 0.03, p < 0.001), cigarette/ e ‐cigarette ( b = 0.04, p < 0.001), and marijuana use ( b = 0.06, p < 0.001) at Y3 (ages 12–13) ( n = 10,213 dyads). Family conflict reported at baseline was not found to moderate these associations. Conclusions Cumulative ACEs exposure was associated with increased risk for future alcohol, cigarette/ e ‐cigarette, and marijuana use among a national sample of young adolescents. Findings highlight the potential for trauma‐informed, developmentally appropriate preventative interventions to mitigate risk for future substance use among adversity‐impacted adolescents.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →